Form 4: Nlight CEO Scott Keeney Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Nlight's CEO, Scott Keeney, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Scott Keeney, the President and CEO of Nlight, Inc., executed stock options to acquire common stock at a price of $0.75 per share.
- He then sold these shares on September 25 and 26, 2024, at weighted average prices of $10.43 and $10.59, respectively.
- These transactions were conducted under a Rule 10b5-1 trading plan.
- Following these transactions, Keeney still beneficially owns 1,347,781 shares of Nlight common stock.
- The sales involved transactions ranging from $10.39 to $10.51 per share on September 25 and $10.42 to $10.80 per share on September 26.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information. The laser and photonics industry is competitive, and insider transactions are always scrutinized by investors.
Comparison to Industry Standards
- Comparing Scott Keeney's transactions to other CEOs in the laser technology sector is difficult without specific data on their compensation structures and trading activities.
- However, it's standard practice for executives at publicly traded companies like IPG Photonics or Coherent to utilize 10b5-1 plans for managing their stock holdings.
- The size and frequency of these transactions are generally in line with industry norms for executive compensation and stock management.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the transactions were pre-planned and not based on current inside information.
- Employees may be indirectly affected by any perceived change in leadership confidence, although the routine nature of the transactions should minimize any such impact.
Key Dates
| Date | Description |
|---|---|
| 02/26/2016 | Date the stock option grant became fully vested and exercisable |
| 02/26/2025 | Expiration date of the stock options |
| 09/25/2024 | Date of stock option exercise and sale of shares |
| 09/26/2024 | Date of stock option exercise and sale of shares |
| 09/27/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.